Literature DB >> 30338585

Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging Neisseria meningitidis lineage 11.2 urethritis clade: mutations in the pilMNOPQ operon.

Yih-Ling Tzeng1, Zachary Berman1, Evelyn Toh2, Jose A Bazan3,4, Abigail Norris Turner3, Adam C Retchless5, Xin Wang5, David E Nelson2, David S Stephens1,6.   

Abstract

Clusters of Neisseria meningitidis (Nm) urethritis among primarily heterosexual males in multiple US cities have been attributed to a unique non-encapsulated meningococcal clade (the US Nm urethritis clade, US_NmUC) within the hypervirulent clonal complex 11. Resistance to antimicrobial peptides (AMPs) is a key feature of urogenital pathogenesis of the closely related species, Neisseria gonorrhoeae. The US_NmUC isolates were found to be highly resistant to the model AMP, polymyxin B (PmB, MICs 64-256 µg ml-1 ). The isolates also demonstrated stable subpopulations of heteroresistant colonies that showed near total resistant to PmB (MICs 384-1024 µg ml-1 ) and colistin (MIC 256 µg ml-1 ) as well as enhanced LL-37 resistance. This is the first observation of heteroresistance in N. meningitidis. Consistent with previous findings, overall PmB resistance in US_NmUC isolates was due to active Mtr efflux and LptA-mediated lipid A modification. However, whole genome sequencing, variant analyses and directed mutagenesis revealed that the heteroresistance phenotypes and very high-level AMP resistance were the result of point mutations and IS1655 element movement in the pilMNOPQ operon, encoding the type IV pilin biogenesis apparatus. Cross-resistance to other classes of antibiotics was also observed in the heteroresistant colonies. High-level resistance to AMPs may contribute to the pathogenesis of US_NmUC.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30338585      PMCID: PMC6351203          DOI: 10.1111/mmi.14153

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.979


  67 in total

Review 1.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

2.  Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.

Authors:  Brooke A Napier; Victor Band; Eileen M Burd; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

3.  Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp.

Authors:  Lori A S Snyder; Sarah A Butcher; Nigel J Saunders
Journal:  Microbiology       Date:  2001-08       Impact factor: 2.777

4.  Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein.

Authors:  T Tønjum; D A Caugant; S A Dunham; M Koomey
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

5.  The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Anup Datta; Karita Ambrose; Miranda Lo; John K Davies; Russell W Carlson; David S Stephens; Charlene M Kahler
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

6.  PilM/N/O/P proteins form an inner membrane complex that affects the stability of the Pseudomonas aeruginosa type IV pilus secretin.

Authors:  M Ayers; L M Sampaleanu; S Tammam; J Koo; H Harvey; P L Howell; L L Burrows
Journal:  J Mol Biol       Date:  2009-11-20       Impact factor: 5.469

7.  Genetic Transformation as a tool for detection of Neisseria gonorrhoeae.

Authors:  A Janik; E Juni; G A Heym
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

8.  Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin in Salmonella enterica.

Authors:  Karin Hjort; Hervé Nicoloff; Dan I Andersson
Journal:  Mol Microbiol       Date:  2016-08-02       Impact factor: 3.501

9.  Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections.

Authors:  Dominique H Limoli; Andrea B Rockel; Kurtis M Host; Anuvrat Jha; Benjamin T Kopp; Thomas Hollis; Daniel J Wozniak
Journal:  PLoS Pathog       Date:  2014-04-24       Impact factor: 6.823

10.  Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles.

Authors:  Adam C Retchless; Cécilia B Kretz; How-Yi Chang; Jose A Bazan; A Jeanine Abrams; Abigail Norris Turner; Laurel T Jenkins; David L Trees; Yih-Ling Tzeng; David S Stephens; Jessica R MacNeil; Xin Wang
Journal:  BMC Genomics       Date:  2018-03-02       Impact factor: 3.969

View more
  4 in total

1.  Evaluation of Urethrotropic-Clade Meningococcal Infection by Urine Metagenomic Shotgun Sequencing.

Authors:  Adam C Retchless; Mark Itsko; Jose A Bazan; Abigail Norris Turner; Fang Hu; Sandeep J Joseph; Alexandria Carter; Morgan Brown; Brandon Snyder; Xin Wang
Journal:  J Clin Microbiol       Date:  2021-11-24       Impact factor: 11.677

Review 2.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29

3.  Development of a SimpleProbe real-Time PCR Assay for rapid detection and identification of the US novel urethrotropic clade of Neisseria meningitidis ST-11 (US_NmUC).

Authors:  Evelyn Toh; James A Williams; Brahim Qadadri; Aaron Ermel; David E Nelson
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

4.  Colistin Resistance Mechanisms in Human Salmonella enterica Strains Isolated by the National Surveillance Enter-Net Italia (2016-2018).

Authors:  Daniela Fortini; Slawomir Owczarek; Anna Maria Dionisi; Claudia Lucarelli; Sergio Arena; Alessandra Carattoli; Laura Villa; Aurora García-Fernández
Journal:  Antibiotics (Basel)       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.